Streetbeat News

Stock Prices

HBIO

Harvard Bioscience, Inc. (NASDAQ:HBIO) is set to join the Russell 2000 and Russell 3000 Indexes, according to preliminary membership information. The addition will become effective after the U.S. market opens on June 26, 2023.

Portfolio Pulse from Charles Gross

June 22, 2023 | 11:57 am

NDVAF

SNDL

SNDL Inc. has disposed of 3.3 million common shares in Indiva Limited, reducing its stake from 12.93% to 8.57%. The shares were sold through the TSX Venture Exchange at an average price of $0.0293 per share, totaling $90,207.

Portfolio Pulse from Vuk Zdinjak

June 22, 2023 | 11:53 am

ROOT

Root, Inc. shares gained 50.1% in pre-market trading following a report suggesting the company has received a takeover bid. Other stocks with significant pre-market movements include ShiftPixy, T2 Biosystems, DSS, Tempo Automation, Siyata Mobile, Aeglea BioTherapeutics, Applied Optoelectronics, U.S. Gold Corp, and Ault Disruptive Technologies.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 11:51 am

HNHPF

RIDE

Lordstown Motors Corp (NASDAQ:RIDE) shares are trading higher after founder Steve Burns sold his remaining stake in the company. Burns has sold about $66 million of stock through mid-June as the company struggled with production issues and a fight with Foxconn Ventures Pte Ltd.

Portfolio Pulse from Anusuya Lahiri

June 22, 2023 | 11:41 am

NRG

NRG Energy anticipates a 15%-20% compounded annual increase in Free Cash Flow Before Growth (FCFbG) per share between 2023 and 2027.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 11:39 am

BA

SPR

Spirit AeroSystems employees, represented by the International Association of Machinists and Aerospace Workers, have decided to strike, causing factory production suspension. This will impact Boeing, as the plant produces 70% of its narrow-body aircraft and defense and business jet structures. Both Boeing and Spirit AeroSystems stocks are falling in response to the news.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 11:36 am

ROIV

Roivant reports positive long-duration data for RVT-3101 from TUSCANY-2 Phase 2b study in ulcerative colitis, showing improved clinical remission and endoscopic improvement. The treatment was well tolerated and had a favorable safety profile.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 11:36 am

TALS

Talaris Therapeutics and Tourmaline Bio have agreed to merge in an all-stock transaction, with the combined company focusing on advancing Tourmaline's lead program, TOUR006. The new company will be named Tourmaline Bio, Inc. and trade under the ticker symbol 'TRML' on Nasdaq. Talaris plans to pay a cash dividend of up to $64.8 million to its stockholders before the merger.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 11:34 am

BHVN

IMTX

NAUT

VALN

ZURA

The article lists the top 5 overbought health care stocks that may crash this month, based on their RSI values. The stocks mentioned are Zura Bio Limited (ZURA), Valneva SE (VALN), Biohaven Ltd. (BHVN), Immatics N.V. (IMTX), and Nautilus Biotechnology, Inc. (NAUT).

Portfolio Pulse from Lisa Levin

June 22, 2023 | 11:32 am

RNLSY

Renault SA plans to build electric vehicle (EV) infrastructure in Busan, South Korea, with an aim to produce 200,000 EVs annually at its Busan facilities. The investment range for the plant has not been disclosed.

Portfolio Pulse from Shivani Kumaresan

June 22, 2023 | 11:25 am